PASTINA, PIERPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 2.062
EU - Europa 1.677
AS - Asia 331
AF - Africa 4
OC - Oceania 4
SA - Sud America 1
Totale 4.079
Nazione #
US - Stati Uniti d'America 2.055
GB - Regno Unito 612
IE - Irlanda 334
CN - Cina 183
IT - Italia 162
UA - Ucraina 128
RU - Federazione Russa 116
SE - Svezia 112
FR - Francia 62
SG - Singapore 61
DE - Germania 51
FI - Finlandia 43
VN - Vietnam 30
TR - Turchia 27
ES - Italia 23
BE - Belgio 18
IN - India 18
IR - Iran 7
CA - Canada 6
AU - Australia 4
LT - Lituania 4
CI - Costa d'Avorio 3
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
NL - Olanda 2
NO - Norvegia 2
PL - Polonia 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
CL - Cile 1
JP - Giappone 1
PA - Panama 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 4.079
Città #
Southend 565
Dublin 324
Fairfield 288
Chandler 169
Ashburn 156
Woodbridge 136
Ann Arbor 125
Santa Clara 122
Wilmington 112
Seattle 110
Houston 105
Menlo Park 104
Jacksonville 103
Cambridge 85
Siena 65
Singapore 52
New York 50
Beijing 43
Princeton 43
Fremont 40
Dong Ket 30
Nanjing 28
Dearborn 27
Helsinki 27
Izmir 27
Málaga 23
Shanghai 21
Brussels 18
Boardman 17
San Diego 15
Florence 14
San Mateo 14
Munich 12
Shenyang 12
Moscow 11
Hebei 9
Tianjin 8
Nanchang 7
Ningbo 7
Jiaxing 6
Lancaster 6
Zanjan 6
Espoo 5
Fort Worth 5
Los Angeles 5
Phoenix 5
Changsha 4
Guangzhou 4
Hangzhou 4
Hounslow 4
Kunming 4
Reggio Calabria 4
Renton 4
Abidjan 3
Fuzhou 3
Jinan 3
Sacramento 3
San Vitaliano 3
Taizhou 3
Toronto 3
Zhengzhou 3
Bologna 2
Changchun 2
Dhaka 2
Falkenstein 2
Frankfurt am Main 2
Henderson 2
Kilburn 2
Lanzhou 2
Leinì 2
London 2
Milan 2
Oslo 2
Prague 2
Priocca 2
Redwood City 2
Sezze 2
Shenzhen 2
Vienna 2
Wuhan 2
Alghero 1
Atlanta 1
Auburn Hills 1
Bagnoli del Trigno 1
Bangalore 1
Borghetto Lodigiano 1
Brainerd 1
Campi Bisenzio 1
Canberra 1
Caserta 1
Cessaniti 1
Chaoyang 1
College Station 1
Crotone 1
Dallas 1
Delhi 1
Edinburgh 1
Gauteng 1
Giussano 1
Islamabad 1
Totale 3.272
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 254
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 246
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 232
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 215
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 205
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 189
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 186
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 179
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 178
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 163
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 162
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 159
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 152
null 139
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 138
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 136
null 130
null 126
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 125
null 117
null 92
null 82
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy 70
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 63
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 63
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 58
In Regard to Kubicek et al. 51
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 51
Immunotherapy of colorectal cancer: new perspectives after a long path. 42
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 41
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 41
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 37
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 27
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 13
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 5
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 5
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review 5
Totale 4.177
Categoria #
all - tutte 12.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020506 0 0 0 0 0 81 81 106 92 67 37 42
2020/2021624 25 76 10 56 45 83 16 82 49 87 19 76
2021/2022388 25 38 38 18 25 18 20 29 29 38 39 71
2022/2023533 26 60 77 80 50 86 11 40 51 31 9 12
2023/2024539 9 6 63 23 15 150 240 0 2 12 2 17
2024/2025382 27 36 110 52 109 48 0 0 0 0 0 0
Totale 4.177